ANI Pharmaceuticals Inc.

NASDAQ: ANIP · Real-Time Price · USD
87.42
-2.58 (-2.87%)
At close: Aug 15, 2025, 3:59 PM
87.47
0.06%
After-hours: Aug 15, 2025, 04:20 PM EDT

ANI Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
8.55M 15.68M -10.28M -22.36M -2.29M 18.21M 1.16M 9.94M 6.25M 1.44M -4.24M -8.6M -14.92M -20.13M -24.14M -4.45M -14.11M 86K
Depreciation & Amortization
23.28M 22.89M 22.6M 15.75M 14.7M 14.69M 15.19M 15.21M 14.69M 14.7M 15.57M 15.35M 14.17M 14.56M 13.68M 11.35M 11.32M 10.9M
Stock-Based Compensation
9.6M 8.87M 7.06M 7.49M 7.86M 6.93M 5.62M 5.44M 5.25M 4.34M 3.74M 3.87M 3.76M 3.24M 2.97M 2.81M 2.84M 1.87M
Other Working Capital
39.56M -5.38M 28.23M 9.33M 1.93M -8.77M 12.86M 8.18M -3.94M 2.69M 3.64M -6.96M 12.82M -5.31M -9.51M -4.29M 5.61M 267K
Other Non-Cash Items
1.68M -10.39M 18.79M 8.86M 3.54M -14.44M 3.32M -731K 2.08M 1.95M 2.92M 4.62M -283K 1.74M 3.3M 577K 569K 572K
Deferred Income Tax
-3.54M -3.38M -17.53M -5.59M -1.9M 3.1M -8.35M -3.26M -910K 773K -1.63M -2.25M -3.91M -7.46M -8.09M -1.99M -6.4M -279K
Change in Working Capital
36.24M 1.33M -4.78M 8.33M -4.5M -10.22M 27.8M 5.57M -6.73M -1.77M -20.76M -9.37M -10.29M -10.88M 84K -13.7M 6.01M 7.52M
Operating Cash Flow
75.81M 34.99M 15.86M 12.47M 17.41M 18.27M 44.74M 32.17M 20.63M 21.42M -4.4M 3.62M -11.48M -18.94M -12.19M -5.4M 241K 20.67M
Capital Expenditures
-4.01M -19.85M -2.48M -5.44M -4.45M -4.58M -4.78M -4.55M -6.83M -2.35M -3.14M -9.81M -1.32M -2.18M -368K -583K -21.95M -737K
Cash Acquisitions
n/a n/a -8.2M -406.59M n/a 13.51M n/a n/a n/a n/a n/a -33K 717K n/a -84.49M n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a -17.37M -86K -959K n/a n/a n/a n/a -4.33M -4K -4K 33K 750K -229K 2.65M -12K -21.02M -39K
Investing Cash Flow
-6.91M -19.85M -10.68M -398.52M -4.45M 8.93M -4.78M -4.55M -6.83M -2.35M -3.14M -9.81M -604K -2.18M -82.21M -583K -21.95M -737K
Debt Repayment
-2.03M -2.03M -2.03M 348.75M -750K -750K -750K -750K -750K -750K -750K -750K -750K -750K 83.06M -2.83M -2.83M -2.38M
Common Stock Repurchased
-551K -10M -318K -680K -1.3M -8.66M -231K -670K -537K -3.55M -119K -239K -483K -1.12M -1K -73K -468K -348K
Dividend Paid
-407K -406K -406K -406K -407K -406K -406K -406K -407K -406K -407K -406K -407K -405K -190K n/a n/a n/a
Other Financial Acitivies
n/a 2.53M 8.49M -57.83M n/a -9.91M -10.53M n/a -2.8M 157K 768K 484K 203K 3K 96.58M -121K 24.2M n/a
Financial Cash Flow
-1.75M -9.91M -4.91M 291.03M -1.45M -19.73M -11.92M 3.75M 80.15M -4.55M -508K -911K -1.44M -2.27M 179.44M -3.02M 20.9M -2.73M
Net Cash Flow
68M 4.94M -123K -95.09M 11.51M 7.48M 28.04M 31.37M 93.95M 14.52M -8.05M -7.1M -13.53M -23.39M 85.05M -9.01M -811K 17.21M
Free Cash Flow
75.81M 15.14M 13.38M 7.03M 12.96M 13.69M 39.96M 27.62M 13.8M 19.07M -7.54M -6.19M -12.8M -21.12M -12.55M -5.99M -21.71M 19.93M